Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis

Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis

AimsWe performed this meta-analysis to evaluate the efficacy and safety of glucagon-like peptide-1 receptor-agonists (GLP-1RA) treatment on cardio-metabolic parameters among antipsychotic-treated patients with schizophrenia.MethodsWe searched the Web of Science, Cochrane Central Register of Controll...

Full description

Bibliographic Details
Main Authors: Abdulrhman Khaity, Nada Mostafa Al-dardery, Khaled Albakri, Omar A. Abdelwahab, Mahmoud Tarek Hefnawy, Yaman A. S. Yousef, Ruaa E. Taha, Sarya Swed, Wael Hafez, Rene Hurlemann, Mohamed E. G. Elsayed
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Psychiatry
Subjects:
schizophrenia
systematic review
meta-analysis
GLP-1 receptor agonists
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1153648/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1153648/full

Similar Items